Speakers

The 2016 FierceBiotech Drug Development Forum’s  conference program will feature innovative and timely education sessions lend by leading industry experts. See the list of confirmed speakers below.

Alan Butcher

Alan
Butcher

Purdue Pharma

Alan Butcher joined Purdue in April 2015.

Alan Crane

Alan
Crane

Polaris Partners

Alan Crane joined Polaris Partners in 2002 and serves as both a Partner and...

Alex Parker

Alex
Parker

Foundation Medicine

Dr. Parker joined Foundation Medicine in 2010 as Director, Technology Innovation.

Amirah Al Idrus

Amirah
Al Idrus

FierceBiotech & FierceMedicalDevices

Amirah Al Idrus is a copy editor for the FierceMarkets Life Sciences group and...

Anna Protopapas

Anna
Protopapas

Mersana Therapeutics

Ms. Protopapas joined Mersana in March 2015, bringing a substantial track record of executive...

Anne Altmeyer

Anne
Altmeyer

Shire Pharmaceuticals

Anne has about 20 years of experience in the Pharmaceutical Industry working in positions...

Arlene Weintraub

Arlene
Weintraub

FierceBiotech

Arlene Weintraub has over 15 years of experience writing about health care, pharmaceuticals and...

Barry Ticho

Barry
Ticho

Moderna Therapeutics

Barry leads Moderna’s efforts to deliver messenger RNA Therapeutics to treat serious Cardiovascular and...

Beth Snyder Bulik

Beth
Snyder Bulik

FiercePharmaMarketing

Beth Snyder Bulik writes for FiercePharmaMarketing. She has been a freelance journalist for 12...

Brian Hagerty

Brian
Hagerty

New York Stock Exchange

Brian leads the Healthcare Capital Markets efforts for the NYSE.

Bruce Booth

Bruce
Booth

Atlas Venture

Bruce Booth is a partner at Atlas Venture, where he helps create and fund...

Carly Helfand

Carly
Helfand

FiercePharma & FiercePharmaMarketing

Carly Helfand is a news editor with FierceMarkets' Life Sciences group, writing for FiercePharma...

Carol Gallagher

Carol
Gallagher

New Enterprise Associates

Carol Gallagher joined New Enterprise Associates (NEA) in October 2014, where she is primarily...

Caroline Stark Beer

Caroline
Stark Beer

Alnylam

Bio coming soon!

Chandra Ramanathan

Chandra
Ramanathan, Ph.D

Bayer HealthCare LLC

Chandra Ramanathan is the VP and Head of East Coast Innovation Center at Bayer.

Chris Apolito

Chris
Apolito

Triangle Insights Group, LLC

Chris Apolito has over fifteen years of pharmaceutical and biotechnology experience, with positions in...

Colleen Feriod

Colleen Feriod
Cuffaro, PhD

Canaan Partners

Colleen joined Canaan Partner’s healthcare investment team in 2014.

Cornell Stamoran

Cornell
Stamoran, Ph.D.

Vice President, Strategy, Catalent, Inc., Founder and Co-Chair, Catalent Applied Drug Delivery Institute

Cornell Stamoran serves as Vice President of Strategy and Government Affairs for Catalent, Inc....

Cynthia Verst

Cynthia
Verst

Quintiles

Cynthia L. Verst is president of Clinical Operations at Quintiles, a position she was...

Damian Garde

Damian
Garde

STAT

Damian Garde reports on biotech in the industry hotbed of Kendall Square for STAT....

David Brush

David
Brush, MS, MBA

Johnson & Johnson Innovation

David is Senior Director of Transactions at the Johnson & Johnson Innovation, Boston.

David Sherris

David
Sherris

GenAdam Therapeutics, Inc.

Dr. Sherris has over 30 years of experience in basic research, biopharmaceuticals and diagnostics.

David Van Sickle

David
Van Sickle

Propeller Health

David Van Sickle, PhD, is a co-founder and CEO of Propeller Health, a digital...

Deborah Dunsire

Deborah
Dunsire

Southern Cross Biotech Consulting

Deborah Dunsire is an industry leader who brings more than 25 years of scientific,...

Diane Beatty

Diane M.
Beatty, PhD

Cardinal Health Specialty Solutions

Diane M. Beatty, PhD, is Managing Director, Regulatory Affairs and Product Development, for the...

Donald Raineri

Donald L.
Raineri, PhD

Astellas

Dr. Donald Raineri is vice president for Regulatory Affairs-Americas at Astellas.

Eric McCafferty

Eric J.
McCafferty

PPDI

An accomplished leader with 15 years experience in pharmaceuticals across operations, strategy, M&A and...

Eric Palmer

Eric
Palmer

FiercePharma

Eric Palmer is a business and technology journalist with more than three decades of...

Eric Perakslis

Eric
Perakslis

Takeda Pharmaceuticals International Co.

Eric is the Executive Director of the Center for Biomedical Informatics and the Countway...

Etienne Drouet

Etienne
Drouet

SynteractHCR

For two-plus decades, Etienne Drouet has focused on oncology clinical development.

Henry Rath

Henry
Rath

Seres Therapeutics Inc.

Henry Rath is the Vice President of Business Development at Seres Therapeutics Inc. ("Seres").

Issi Rozen

Issi
Rozen

Broad Institute of MIT and Harvard

Issi Rozen, Chief Business Officer at the Broad Institute of Harvard and MIT, is responsible...

Jake Beverage

Jake
Beverage, PharmD

Sirenas

Dr. Jake Beverage, PharmD, co-founded Sirenas Marine Discovery LLC in 2011 and serves as...

James Roach

James
Roach

Momenta Pharmaceuticals, Inc.

James M. Roach, M.D., FACP, FCCP has been Senior Vice President, Development and Chief...

Jane Rhodes

Jane
Rhodes

Biogen

Jane Rhodes is Senior Director of New Initiatives in the Value Based Medicine...

JC Gutierrez-Ramos

JC
Gutiérrez-Ramos

Synlogic

Dr. Gutiérrez-Ramos joins Synlogic from Pfizer, where he served as Group Senior Vice President...

Jeb Keiper

Jeb
Keiper

Nimbus Therapeutics

Jeb joined Nimbus in 2014 and is accountable for the financing, business development, commercial,...

Jeff Albers

Jeff
Albers

Blueprint Medicines

Jeff has more than 15 years of experience in leadership roles in the biopharmaceutical...

Jeremy Springhorn

Jeremy
Springhorn

Alexion

Jeremy joined Flagship in 2015 and develops strategic plans for VentureLabs® portfolio companies, works...

John Lewis

John
Lewis

ACRO

John serves as Vice President of Public Affairs for the Association of Clinical Research...

John Oldenhof

John
Oldenhof

INC Research

Dr. John Oldenhof is Executive Director, Clinical Pharmacology at INC Early Phase - Toronto,...

John Orloff

John
Orloff

Biopharma R&D Executive

Dr. Orloff, M.D., is a global R&D/business leader and Chief Scientific Officer with 20...

John Puziss

John
Puziss

Yale University

Dr. Puziss is Director of Technology Licensing at Yale University’s Office of Cooperative Research,...

John Quisel

John
Quisel

Acceleron

Dr. Quisel joined Acceleron in October 2006 and is Senior Vice President, Business Development,...

Jonathan Edelman

Jonathan
Edelman

Seqirus

Dr. Jonathan M. Edelman is Vice President of Clinical Development for Seqirus, a CSL...

Karen Kaucic

Karen
Kaucic, M.D.

PPD® Consulting

Karen Kaucic, M.D., is vice president and global head of PPD® Consulting.

Kathrin Jansen

Kathrin
Jansen

Pfizer

Kathrin U. Jansen, Ph.D., is a Senior Vice President and Head for Vaccine Research...

Keith Horspool

Keith
Horspool

Boehringer-Ingelheim

Keith Horspool is the Vice President of Pharmaceutical Development at Boehringer-Ingelheim, Ridgefield, CT.

Kenneth Kaitin

Kenneth
Kaitin

Tufts University School of Medicine

Dr. Kaitin is a Professor at Tufts University School of Medicine and is Director...

Kevin Bitterman

Kevin
Bitterman

Polaris Partners

Kevin Bitterman is a Partner in the Boston office.

Kimberly Ha

Kimberly
Ha

FTI Consulting

Kimberly Ha is a Senior Director in the FTI Consulting Strategic Communications segment and...

Laura Brass

Laura
Brass, PhD, MBA

MPM Capital

Laura Brass, Ph.D., M.B.A. joined MPM in 2015.

Lloyd Klickstein

Lloyd
Klickstein

Novartis

Lloyd is Head of Translational Medicine for the New Indication Discovery Unit (NIDU) at...

Luba Greenwood

Luba
Greenwood

Roche

Luba Greenwood brings pharmaceutical and biotechnology industry experience and expertise in building and advising...

Marc LeMaitre

Marc
Lemaitre, PhD

Biotech Executive & Independent Consultant

Marc Lemaitre holds a first degree in Organic Chemistry and a PhD in Biochemistry...

Marian Nakada

Marian
Nakada

Johnson & Johnson

Marian is Vice President, Venture Investments at Johnson & Johnson Innovation – JJDC Inc....

Mark Baglin

Mark
Baglin

Shire Pharmaceuticals

Mark is Vice President, Product Strategy Leader, Angioedema within the Shire Genetic Diseases Business...

Mark Barrett

Mark
Barrett

Sanofi Genzyme

Mark Barrett is Head of Business Development for Sanofi Genzyme where he and his...

Markus Peters

Markus
Peters, PhD

Alacrita

Markus Peters, PhD has more than 20 years of cross-functional and transcultural leadership experience...

Matthew Howes

Matthew
Howes

PALIO, an inVentiv Health Company

Matthew has a passion for working with organizations on the forefront of healthcare, and...

Menashe Levy

Menashe
Levy

Teva Pharmaceuticals

Dr. Levy is an entrepreneur, whose 20 years in the bio-pharmaceutical and medical device...

Michael Kauffman

Michael
Kauffman

Karyopharm

Dr. Kauffman co-founded Karyopharm with Dr. Sharon Shacham in 2008 and has served as...

Michal Preminger

Michal
Preminger

Harvard Medical School Office

Michal joined OTD in 2005.

Mike Collins

Mike
Collins

Alexion Pharmaceuticals

Mike has worked in clinical development for over 25 years at Hoechst and Pfizer....

Mike Mentasana

Mike
Mentesana

PwC

Michael is a dynamic consulting executive with more than eighteen years of experience assisting...

Murray Abramson

Murray Alexander
Abramson, MD, MPH

Biogen

Murray Abramson, MD, is currently Vice President of Global Clinical Operations at Biogen Idec....

Murray Robinson

Murray
Robinson, PhD

Molquant, Inc.

With more than 20 years experience exploring the molecular genetics of cancer to drive...

Nancy Thornberry

Nancy
Thornberry

CEO, Kallyope

Nancy was formerly Senior Vice President and Franchise Head, Diabetes and Endocrinology, Merck &...

Nathan Sanburn

Nathan
Sanburn

Eli Lilly & Company

Nathan Sanburn currently serves as the East Region Director in Oncology US Medical Affairs...

Pam Swiggard

Pam
Swiggard

Trevena

Ms. Swiggard joined Trevena in November 2010 as VP and Head, Regulatory Affairs and...

Phil Vickers

Phil
Vickers, PhD

Shire Pharmaceuticals

Dr. Philip J. Vickers, also known as Phil, Ph.D., serves as the Head of...

Rebecca Friend

Rebecca
Willumson

FierceBiotech

Rebecca Willumson is the publisher of FierceMarkets' Life Sciences publications and events overseeing the...

Robert Ashworth

Robert
Ashworth

Advaxis, Inc.

Dr. Robert Ashworth has over 30 years of pharmaceutical industry experience spanning chemistry research...

Ronald Smith

Ronald L.
Smith

Merck Research Laboratories

Dr. Smith joined Merck in 2008 as Executive Director of Pharmaceutical Research in West...

Samantha Truex

Samantha
Truex

Padlock Therapeutics

Samantha Truex is a seasoned biotech professional who most recently served as Chief Business...

Sara Nayeem

Sara
Nayeem, MD

New Enterprise Associates

Sara joined NEA's healthcare team in 2009 and focuses on investments in biopharmaceutical companies....

Shuvayu Sen

Shuvayu
Sen, PhD

Merck & Co.

Shuvayu Sen, Ph.D. is an Executive Director at Merck & Co., Inc. where he leads...

Simon Tulloch

Simon
Tulloch

Faraday Pharmaceuticals

Dr. Tulloch has 30 years of pharmaceutical and biotech experience in clinical development, R&D...

Simos Simeonidis

Simos
Simeonidis

RBC Capital Markets

Dr. Simos Simeonidis is a Managing Director and Senior Biotechnology Analyst at RBC Capital...

Stacy Coen

Stacy
Coen

Sanofi Genzyme

Stacy Coen joined Genzyme in 1997 and has held business development roles of increasing...

Stacy Lawrence

Stacy
Lawrence

FierceBiotech

Stacy Lawrence of FierceBiotech has been writing and editing about the business of emerging...

Stephen Knight

Stephen
Knight

F-Prime Capital

Stephen Knight joined F-Prime Capital in 2003 where he serves as President and Managing...

Steve Dickman

Steve
Dickman

CBT Advisors

CBT Advisors Founder-CEO Steve Dickman has worked in the biotechnology and venture capital industries...

Steve Paul

Steve
Paul, M.D.

Voyager Therapeutics

Steven Paul is our President & CEO, a member of the Board of Directors...

Steven Tregay

Steven
Tregay

FORMA Therapeutics

Steven Tregay is the Founder, President and CEO of FORMA Therapeutics based in Watertown,...

Susan Dillon

Susan
Dillon

Johnson & Johnson

Sue Dillon is the Global Therapeutic Area Head for Immunology for Janssen, Research &...

Susan Washer

Susan
Washer

Applied Genetic Technologies Corporation

Sue Washer has developed an impressive career over the past 32 years, with diverse...

Todd Foley

Todd
Foley

MPM Capital

Todd Foley joined MPM in 1999. Todd focuses on biotech investments and currently serves...

Tony Bower

Tony
Bower

BRG LLC

Dr. Tony Bower is President of BRG LLC, a consultancy dedicated to making biotech...

Tracy Staton

Tracy
Staton

FiercePharma & FiercePharmaMarketing

Tracy Staton is the editor of FiercePharma and FiercePharmaMarketing.

Wende Hutton

Wende
Hutton

Canaan

Healthcare investor Wende Hutton brings 23 years of experience to identifying, investing in and...

Yury Rozenman

Yury
Rozenman

Qualcomm Life

Yury Rozenman currently leads pharmaceutical business development organization at Qualcomm Life.

Sign Up for Forum Updates